IL17A and COVID-19: In the present study, we detected significantly higher serum levels of measured cytokines, chemokines, and inflammatory proteins (IP-10, CRP, IFNγ, IL-10, IL-13, IL-17α, IL-23, and IL-6) in COVID-19 patients than in controls.